Campto

Campto Indications/Uses

irinotecan

Manufacturer:

Pfizer
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
CAMPTO (irinotecan hydrochloride) is indicated for the treatment of patients with advanced colorectal cancer: In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for advanced disease; as a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.
Irinotecan combination with cisplatin is indicated for treatment of patients with small-cell lung cancer.
Strictly follow the recommended dosage unless directed otherwise by the physician.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in